The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2024 | Investigating genomic evolution at the time of relapse in multiple myeloma
Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses his research, which tracks patients with multiple myeloma (MM) from diagnosis to relapse, highlighting the dynamic changes in mutations over time. The findings reveal that some patients experience static myeloma cell patterns while others show significant changes, including persistent and evolving clones. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
